Contribution of Na +-Ca 2+ exchanger to pinacidil-induced relaxation in the rat mesenteric artery

British Journal of Pharmacology

Volumn 138, Issue 3, 2003, Pages 453-460

  Suk, Ying Tsang ^a   Yao, Xiaoqiang ^a   Chi, Ming Wong ^a   Chak, Leung Au ^a   Zhen, Yu Chen ^a   Huang, Yu ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Artery; Na + Ca 2+ exchanger; Pinacidil; Rat; Relaxation; Smooth muscle

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; BENZAMIL; CALCIUM CHANNEL; CYCLIC AMP DERIVATIVE; CYCLOPIAZONIC ACID; GLIBENCLAMIDE; N(G) NITROARGININE; NICKEL; NIFEDIPINE; NITROPRUSSIDE SODIUM; OUABAIN; PHENYLEPHRINE; PHORBOL; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM ION; PROPRANOLOL; PROTEIN INHIBITOR; SODIUM; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CALCIUM EXCHANGE PROTEIN INHIBITOR; THAPSIGARGIN; UNCLASSIFIED DRUG; CALCIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN KINASE C; VASODILATOR AGENT;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; EXTRACELLULAR SPACE; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; MUSCLE CONTRACTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SUPERIOR MESENTERIC ARTERY; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MESENTERIC ARTERY, SUPERIOR; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PINACIDIL; POTASSIUM CHANNEL BLOCKERS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-CALCIUM EXCHANGER; VASODILATION; VASODILATOR AGENTS;

EID: 0037332255     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705062     Document Type: Article

References (28)

1. AHNFELT-RONNE, I. (1988). Pinacidil: History, basic pharmacology, and therapeutic implications. J. Cardiovasc. Pharmacol., 12 (Suppl. 2), S1-S4.
2. ANABUKI, J., HORI, M., OZAKI, H., KATO, I. & KARAKI, H. (1990). Mechanisms of pinacidil-induced vasodilatation. Eur. J. Pharmacol., 190, 373-379.
3. BELL, P.D., MASHBURN, N. & UNLAP, M.T. (2000). Renal sodium/calcium exchange; a vasodilator that is defective in salt-sensitive hypertension. Acta Physiol. Scand., 168, 209-214.
4. + channels in human coronary artery vascular smooth muscle cells. Am. J. Physiol., 273, C161-171.
5. FRIEDEL, H.A. & BROGDEN, R.N. (1990). Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs 39, 929-967.
6. GOJKOVlC BUKARICA, L., KAZIC, T., SAJIC, Z., DJUKANOVlC, B., PANIC, G., PERIC, M. & BOJIC, M. (1997). The effects of levcromakalim and pinacidil on the human internal mammary artery. Fundam. Clin. Pharmacol., 11, 550-560.
7. GOLDBERG, M.R., ROCKHOLD, F.W., THOMPSON, W.L. & DESANTE, K.A. (1989). Clinical pharmacokinetics of pinacidil, a potassium channel opener, in hypertension. J. Clin. Pharmacol., 29, 33-40.
8. GOLLASCH, M., BYCHKOV, R., RIED, C., BEHRENDT, F., SCHOLZE, S, LUFT, F.C. & HALLER, H. (1995). Pinacidil relaxes porcine and human coronary arteries by activating ATP-dependent potassium channels in smooth muscle cells. J. Pharmacol. Exp. Ther., 275, 681-692.
9. + channel blockers on β-adrenoceptor-mediated vasorelaxation of rat mesenteric artery. J. Cardiovasc. Pharmacol., 29, 515-519.
10. ITOH, T., SEKI, N., SUZUKI, S., ITO, S., KAJIKURI, J. & KURIYAMA, H. (1992). Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J. Physiol., 451, 307-328.
11. KALSNER, S. (1994). Propranolol antagonizes coronary artery relaxation by a potassium channel opener. Life. Sci., 55, 1109-1121.
12. 1-adrenoceptor-induced coronary vasodilation in dogs. Am. J. Physiol. Heart Circ. Physiol., 39, H2210-H2215.
13. McBURNEY, A., FARROW, P.R. & WARD, J.W. (1987). Effects of formulation on the pharmacokinetics of orally administered pinacidil in humans. J. Pharm. Sci., 76, 940-941.
14. + channel-dependent as well as -independent components of pinacidil-induced vasodilation. J. Pharmacol. Exp. Ther., 256, 492-499.
15. 2+ exchange in the regulation of vascular smooth muscle tension. Am. J. Physiol. Heart Circ. Physiol., 264, H1028-H1040.
16. 2+ exchange in salt-sensitive hypertension. Am. J. Physiol. Renal Physiol., 45, F567-F573.
17. + channels. Nature, 344, 770-773.
18. PETKOV, G.V., FUSI, F., SAPONARA, S., GAGOV, H.S., SGARAGLI, G.P. & BOEV, K.K. (2001). Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery. Acta Physiol. Scand., 173, 257-265.
19. QUAST, U. (1992). Potassium channel openers: pharmacological and clinical aspects. Fund. Clin. Pharmacol., 6, 279-293.
20. + channels? TIPS, 14, 332-337.
21. RANDALL, M.D. & McCULLOCH, A.I. (1995). The involvement of ATP-sensitive potassium channels in β-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 115, 607-612.
22. SCHWEDA, F., KRAMER, B.K. & KURTZ, A. (2001). Differential roles of the sodium-calcium exchanger in renin secretion and renal vascular resistance. Pflügers Arch., 442, 693-699.
23. + channels in arterial smooth muscle. Science, 245, 177-180.
24. + channels. Biochem. Biophys. Res. Commun., 181, 172-178.
25. +-selective channels causing hyperpolarization and relaxation of noradrenaline contractions in rat mesenteric resistance vessels. Br. J. Pharmacol., 95, 103-108.
26. XIE, L.H., TAKANO, M. & NOMA, A. (1998). The inhibitory effect of propranolol on ATP-sensitive potassium channels in neonatal rat heart. Br. J. Pharmacol., 123, 599-604.
27. XIONG, Z.L., KAJIOKA, S., SAKAI, T., KITAMURA, K, & KURIYAMA, H. (1991). Pinacidil inhibits the ryanodine-sensitive outward current and glibenclamide antagonizes its action in cells from the rabbit portal vein. Br. J. Pharmacol., 102, 788-790.
28. 2+ release in coronary artery. Cardiovasc. Drugs. Ther., 7 (Suppl 3), 565-574.